AtriCure - Stock Price History | ATRC
Historical daily share price chart and data for AtriCure since 2020 adjusted for splits. The latest closing stock price for AtriCure as of August 03, 2020 is 41.63.
- The all-time high AtriCure stock closing price was 51.19 on June 08, 2020.
- The AtriCure 52-week high stock price is 51.76, which is 24.3% above the current share price.
- The AtriCure 52-week low stock price is 22.57, which is 45.8% below the current share price.
- The average AtriCure stock price for the last 52 weeks is 35.29.
| AtriCure Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2019 | 29.1289 | 30.2500 | 33.3400 | 23.8100 | 32.5100 | 6.24% |
| 2018 | 26.1470 | 18.4700 | 35.5800 | 15.0500 | 30.6000 | 67.76% |
| 2017 | 20.3076 | 19.2000 | 24.8800 | 14.9400 | 18.2400 | -6.80% |
| 2016 | 16.5649 | 21.1600 | 21.4700 | 13.5400 | 19.5700 | -12.79% |
| 2015 | 21.8535 | 19.7800 | 27.9300 | 17.4000 | 22.4400 | 12.42% |
| 2014 | 17.5247 | 18.0300 | 22.1800 | 13.6400 | 19.9600 | 6.85% |
| 2013 | 10.3316 | 7.1400 | 18.9300 | 7.1400 | 18.6800 | 170.72% |
| 2012 | 8.5684 | 11.7400 | 11.9600 | 5.9100 | 6.9000 | -37.84% |
| 2011 | 11.4511 | 10.2500 | 14.5000 | 8.5400 | 11.1000 | 8.08% |
| 2010 | 6.7755 | 5.6500 | 10.2700 | 4.5600 | 10.2700 | 70.03% |
| 2009 | 3.2447 | 2.2000 | 6.0500 | 1.0700 | 6.0400 | 172.07% |
| 2008 | 9.7793 | 13.2400 | 14.0500 | 2.0000 | 2.2200 | -83.07% |
| 2007 | 10.6159 | 9.1500 | 13.5900 | 8.4400 | 13.1100 | 46.64% |
| 2006 | 8.1361 | 10.7900 | 11.8000 | 5.4400 | 8.9400 | -16.06% |
| 2005 | 13.1674 | 14.0800 | 14.9500 | 10.6500 | 10.6500 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.871B | $0.231B |
| AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $178.087B | 33.45 |
| Medtronic (MDT) | Ireland | $130.549B | 21.20 |
| Stryker (SYK) | United States | $71.817B | 27.85 |
| Boston Scientific (BSX) | United States | $53.175B | 31.41 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.258B | 0.00 |
| Baxter (BAX) | United States | $42.098B | 25.75 |
| Terumo (TRUMY) | Japan | $29.607B | 37.85 |
| ResMed (RMD) | United States | $29.223B | 46.12 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $28.452B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $28.013B | 17.63 |
| Sunny Optical Technology (SNPTF) | China | $20.336B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $17.809B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $15.744B | 71.28 |
| Insulet (PODD) | United States | $12.772B | 1265.31 |
| Quidel (QDEL) | United States | $12.326B | 65.29 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $12.301B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $11.312B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $8.157B | 41.58 |
| Perrigo (PRGO) | Ireland | $7.465B | 13.36 |
| William Demant Holdings (WILYY) | Denmark | $7.457B | 0.00 |
| Canopy Growth (CGC) | Canada | $7.069B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $6.374B | 15.82 |
| Haemonetics (HAE) | United States | $4.386B | 26.34 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.125B | 0.00 |
| Neogen (NEOG) | United States | $4.103B | 68.55 |
| ICU Medical (ICUI) | United States | $3.829B | 27.93 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.787B | 0.00 |
| Envista Holdings (NVST) | United States | $3.527B | 24.05 |
| Abcam (ABCZY) | $3.484B | 0.00 | |
| Agios Pharmaceuticals (AGIO) | United States | $3.245B | 0.00 |
| NuVasive (NUVA) | United States | $2.857B | 22.94 |
| National Vision Holdings (EYE) | United States | $2.647B | 45.79 |
| TG Therapeutics (TGTX) | United States | $2.293B | 0.00 |
| DFB Healthcare Acquisitions (AHCO) | United States | $1.649B | 151.85 |
| MacroGenics (MGNX) | United States | $1.445B | 0.00 |
| Aphria (APHA) | Canada | $1.413B | 0.00 |
| NanoString Technologies (NSTG) | United States | $1.402B | 0.00 |
| Cerus (CERS) | United States | $1.215B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $1.203B | 0.00 |
| OraSure Technologies (OSUR) | United States | $1.189B | 239.38 |
| Vapotherm (VAPO) | United States | $1.128B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $1.113B | 41.92 |
| Cardiovascular Systems (CSII) | United States | $1.102B | 0.00 |
| Owens & Minor (OMI) | United States | $1.072B | 28.35 |
| InMode (INMD) | Israel | $1.071B | 22.64 |
| PetIQ (PETQ) | United States | $1.055B | 30.47 |
| Phibro Animal Health (PAHC) | United States | $0.946B | 18.86 |
| Quanterix (QTRX) | United States | $0.914B | 0.00 |
| Omeros (OMER) | United States | $0.698B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.671B | 191.00 |
| Zynex (ZYXI) | United States | $0.656B | 57.24 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.653B | 46.78 |
| Surmodics (SRDX) | United States | $0.651B | 78.39 |
| VAREX IMAGING (VREX) | United States | $0.625B | 15.52 |
| LeMaitre Vascular (LMAT) | United States | $0.609B | 37.26 |
| Lantheus Holdings (LNTH) | United States | $0.529B | 12.31 |
| Viemed Healthcare (VMD) | United States | $0.429B | 38.07 |
| Cytosorbents (CTSO) | United States | $0.346B | 0.00 |
| HEXO (HEXO) | $0.336B | 0.00 | |
| Neptune Wellness Solutions (NEPT) | Canada | $0.329B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.294B | 25.26 |
| InfuSystems Holdings (INFU) | United States | $0.249B | 137.67 |
| Organigram Holdings (OGI) | Canada | $0.225B | 0.00 |
| Female Health (VERU) | United States | $0.199B | 0.00 |
| Chimerix (CMRX) | United States | $0.194B | 0.00 |
| Fonar (FONR) | United States | $0.160B | 14.20 |
| Bovie Medical (APYX) | United States | $0.159B | 0.00 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| Surface Oncology (SURF) | United States | $0.148B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.135B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.130B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.122B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.119B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.118B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.110B | 0.00 |
| Evolus (EOLS) | United States | $0.102B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.089B | 0.00 |
| Nephros (NEPH) | United States | $0.074B | 0.00 |
| United-Guardian (UG) | United States | $0.068B | 15.87 |
| Brainsway (BWAY) | Israel | $0.067B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.058B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.035B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.031B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.029B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.021B | 0.00 |
| Myomo (MYO) | United States | $0.011B | 0.00 |
| Conatus Pharmaceuticals (HSTO) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.006B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.004B | 0.00 |
